Arkolith/Insider Trading/REGN/Form 4

Bassler Bonnie L

DirectorREGENERON PHARMACEUTICALS, INC. (REGN) · full profile →Form 4 · filed Jan 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Sell(S)2K$800.00$1.2M2K
Jan 7, 2026Option exercise(M)2K$374.12$561K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)2K—$03K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683607-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML